These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 38707615)

  • 1. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs.
    Liu Y; Liang Y; Yuhong J; Xin P; Han JL; Du Y; Yu X; Zhu R; Zhang M; Chen W; Ma Y
    Drug Des Devel Ther; 2024; 18():1469-1495. PubMed ID: 38707615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent update of toxicity aspects of nanoparticulate systems for drug delivery.
    Patnaik S; Gorain B; Padhi S; Choudhury H; Gabr GA; Md S; Kumar Mishra D; Kesharwani P
    Eur J Pharm Biopharm; 2021 Apr; 161():100-119. PubMed ID: 33639254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanocrystal technology in the delivery of poorly soluble drugs: an overview.
    Nagarwal RC; Kumar R; Dhanawat M; Das N; Pandit JK
    Curr Drug Deliv; 2011 Jul; 8(4):398-406. PubMed ID: 21453258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanonization techniques to overcome poor water-solubility with drugs.
    Da Silva FLO; Marques MBF; Kato KC; Carneiro G
    Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoemulsion as Oral Drug Delivery - A Review.
    Sabjan KB; Munawar SM; Rajendiran D; Vinoji SK; Kasinathan K
    Curr Drug Res Rev; 2020; 12(1):4-15. PubMed ID: 31774040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs.
    Khan KU; Minhas MU; Badshah SF; Suhail M; Ahmad A; Ijaz S
    Life Sci; 2022 Feb; 291():120301. PubMed ID: 34999114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
    Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
    Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances and patents in solid dispersion technology.
    Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
    Silva AC; Santos D; Ferreira D; Lopes CM
    Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Enhancing Oral Drug Absorption: Overcoming Physiological and Pharmaceutical Barriers for Improved Bioavailability".
    Maurya R; Vikal A; Patel P; Narang RK; Kurmi BD
    AAPS PharmSciTech; 2024 Oct; 25(7):228. PubMed ID: 39354282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocrystal for ocular drug delivery: hope or hype.
    Sharma OP; Patel V; Mehta T
    Drug Deliv Transl Res; 2016 Aug; 6(4):399-413. PubMed ID: 27165145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticles for the delivery of poorly water-soluble drugs.
    Bunjes H
    J Pharm Pharmacol; 2010 Nov; 62(11):1637-45. PubMed ID: 21039547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS).
    Rehman FU; Shah KU; Shah SU; Khan IU; Khan GM; Khan A
    Expert Opin Drug Deliv; 2017 Nov; 14(11):1325-1340. PubMed ID: 27485144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical Amorphous Nanoparticles.
    Jog R; Burgess DJ
    J Pharm Sci; 2017 Jan; 106(1):39-65. PubMed ID: 27816266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability enhancers of herbal origin: an overview.
    Kesarwani K; Gupta R; Mukerjee A
    Asian Pac J Trop Biomed; 2013 Apr; 3(4):253-66. PubMed ID: 23620848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern drug delivery strategies applied to natural active compounds.
    Puglia C; Lauro MR; Tirendi GG; Fassari GE; Carbone C; Bonina F; Puglisi G
    Expert Opin Drug Deliv; 2017 Jun; 14(6):755-768. PubMed ID: 27606793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous materials and nanocrystals for enhancing the dissolution behavior of poorly water-soluble drugs.
    Santos HA; Peltonen L; Limnell T; Hirvonen J
    Curr Pharm Biotechnol; 2013; 14(10):926-38. PubMed ID: 24372243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of solid lipid nanoparticles-a review.
    Parhi R; Suresh P
    Curr Drug Discov Technol; 2012 Mar; 9(1):2-16. PubMed ID: 22235925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.